Compare GPMT & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | CSBR |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | 28 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.9M | 81.0M |
| IPO Year | N/A | 2015 |
| Metric | GPMT | CSBR |
|---|---|---|
| Price | $1.38 | $5.82 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 173.0K | 5.6K |
| Earning Date | 05-05-2026 | 03-12-2026 |
| Dividend Yield | ★ 12.99% | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,900,000.00 |
| Revenue This Year | $458.85 | $4.84 |
| Revenue Next Year | $8.63 | $11.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.24 | $5.50 |
| 52 Week High | $3.12 | $8.74 |
| Indicator | GPMT | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 42.63 | 47.25 |
| Support Level | $1.24 | $5.90 |
| Resistance Level | $1.57 | $6.31 |
| Average True Range (ATR) | 0.07 | 0.44 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 26.53 | 27.24 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.